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Abstract
Carboxyhemoglobin levels in blood reflect endogenous carbon monoxide production and
are often measured during routine blood gas analysis. Endogenous carbon monoxide pro-
duction has been reported to be increased during sepsis, but carboxyhemoglobin levels
have not been thoroughly evaluated as a biomarker of sepsis. We sought to determine
whether carboxyhemoglobin levels were elevated during sepsis in a high risk population of
premature neonates. We conducted a retrospective cohort study of 30 infants in two neona-
tal intensive care units using electronic medical and laboratory records. The majority of
infants were extremely premature and extremely low birth weight, and 25 had at least one
episode of sepsis. We collected all carboxyhemoglobin measurements during their in-
patient stay and examined the relationship between carboxyhemoglobin and a variety of
clinical and laboratory parameters, in addition to the presence or absence of sepsis, using
linear mixed-effect models. We found that postnatal age had the most significant effect on
carboxyhemoglobin levels, and other significant associations were identified with gesta-
tional age, hemoglobin concentration, oxyhemoglobin saturation, and blood pH. Accounting
for these covariates, there was no significant relationship between the onset of sepsis and
carboxyhemoglobin levels. Our results show that carboxyhemoglobin is unlikely to be a clin-
ically useful biomarker of sepsis in premature infants, and raise a note of caution about fac-
tors which may confound the use of carbon monoxide as a clinical biomarker for other
disease processes such as hemolysis.
Introduction
Blood gas analysis is one of the main methods used to monitor the effectiveness of ventilation
and metabolic status of preterm infants [1]. Many clinical blood gas analysers in current use
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have a co-oximetry module, used primarily by clinicians to give an estimate of hemoglobin
concentration, but also reporting carboxyhemoglobin (COHb) and methemoglobin (MetHb)
levels. Consequently many co-oximetry measurements are performed on sick neonates
although the COHb levels are rarely noted by clinicians. The recognition of endogenously pro-
duced carbon monoxide (CO) as a molecule with unique physiological properties [2, 3], and as
a clinically useful indicator of hemolysis and other pathological states, has renewed interest in
methods for its detection [4–7].
Endogenous CO production mainly arises from heme catabolism by heme oxygenase (HO)
enzymes, along with two other degradation products: iron and biliverdin [8]. The inducible iso-
form of HO is HO-1 [9], and aside from its role in heme catabolism it has also been shown to
have an indispensable cytoprotective role in the cellular response to a wide variety of harmful
stimuli [10, 11] including an essential function for survival in animal infection models such as
malaria and bacterial sepsis [12–14]. HO-1 is encoded by theHMOX1 gene in humans located
on chromosome 22 q12 [15] and is largely regulated at the transcriptional level [16–18]. An
increase in heme degradation by HO-1 results in a detectable increase in CO production,
blood levels of COHb, and CO excretion in breath [19–21]. This increase in CO production
has been demonstrated in a variety of hemolytic anemias, including hemolytic disease of the
newborn and ABO incompatibility [4, 7, 19, 21]. In addition, increased CO production has
been observed following non-heme induction of HO-1, for example during the systemic
inflammatory response syndrome due to trauma or infection [22–26].
Neonatal sepsis causes a huge burden of disease globally [27]. Even in well-resourced set-
tings, early-onset sepsis remains a significant cause of neonatal morbidity and mortality, whilst
late-onset sepsis, particularly nosocomial sepsis accompanying neonatal intensive care for pre-
maturely born infants, is a major problem [28]. Very low birth weight (VLBW,<1500g) infants
are at high risk of developing sepsis in the neonatal period and using conservative estimates, at
least 15% will develop culture-proven sepsis [28]. Many more infants will be suspected to have
bacterial sepsis based on clinical features and laboratory investigations, but blood cultures will
not yield an organism. Furthermore, the diagnosis of sepsis is often complicated because tradi-
tional measures of the host-response to infection, such as C-reactive protein and white blood
cell count, may lack sensitivity in neonates [28, 29]. For this reason, new methods of identifying
the onset of sepsis are highly desirable [30], and might allow more rational use of antibiotics—
avoiding selection of resistant organisms and changes in the early gut microbiota [31]. We
wondered if COHb might be a useful indicator of the onset of sepsis in neonates.
The aim of the present study was to identify patient characteristics and physiological param-
eters associated with COHb concentrations in a retrospective cohort of neonates admitted to
two neonatal units in the UK, and then test the hypothesis that COHb concentrations were
increased at the onset of episodes of sepsis. We identified multiple determinants of COHb,
with postnatal age having the strongest effect, although the onset of sepsis did not appear to
significantly influence COHb concentrations. Nevertheless, these results will be useful when
considering interpretation of COHb levels for other purposes such as identification of patho-
logical hemolysis.
Materials and Methods
Study design and subject identification
The study was approved by the National Research Ethics Committee South Central—Hamp-
shire A (Reference 15_SC_0263) and the Joint Research Compliance Office of Imperial College
London and Imperial College Healthcare NHS Trust (ICHT). We performed a retrospective
analysis using prospectively collected electronic routine clinical and laboratory data from the
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neonatal units at St Mary’s and Queen Charlotte’s Hospitals, which are both part of ICHT. To
minimise any inclusion bias, individual consent was not obtained for access to the health rec-
ords, which was acceptable because records were only accessed by members of the patient care
team, and only pseudoanonymised data was used for analysis. The Vermont Oxford Network
2014 Manual of Operations Part 2, Release 18.0 (https://public.vtoxford.org/membership/
member-tools/manuals-forms/) was used to define all clinical events, since this was the basis
for recording outcomes in the neonatal electronic records. Any infant admitted on the neonatal
units at St Mary’s Hospital or Queen Charlotte’s Hospital between June 2014 and June 2015
with at least two COHb measurements was potentially eligible for inclusion. Exclusion criteria
were: proven or suspected hemolytic disorder (increases COHb); necrotizing entercolitis (from
24 hours prior to clinical suspicion; increased HO-1 expression [32] is likely to increase COHb
and confound identification of sepsis); nitric oxide therapy or therapeutic cooling (for the
duration of this therapy because effect on COHb is unknown); major congenital malformations
(may influence clinical suspicion of sepsis). The group of infants with at least one episode of
sepsis was composed of all infants who met the Vermont Oxford Network definition of early
or late sepsis and had at least one COHb measurement at “onset” of sepsis (defined as the inter-
val from six hours before the sample yielding a positive culture was obtained or six hours before
starting treatment, until 24hrs after start of appropriate antimicrobial treatment). A second
group of infants without sepsis was identified from all infants who never met Vermont Oxford
Network definition of early or late sepsis, and did not receive any antibiotic treatment for sus-
pected sepsis after the first 48 hours of life (the period in which almost all preterm neonates
received empirical antibiotic cover according to unit protocols). Infants without sepsis were
selected from all eligible patients by matching gestational age to a random selection of infants
with sepsis.
Data collection and analysis. Blood gas analysis and co-oximetry was performed using
GEM4000 analysers (Instrumentation Laboratory) and results were automatically transferred
to the hospital electronic laboratory record system. Electronic laboratory results together with
the time and date of sample collection were extracted using CERNER Powerchart (CERNER
corporation). Demographic and clinical data was extracted from the BadgerNet neonatal elec-
tronic patient records (Clevermed). We collected information on the following parameters:
organisms grown from sterile site cultures; blood gas pH, COHb (%), oxyhemoglobin (%), met-
hemoglobin (%), hemoglobin concentration; neonatal unit (St Mary’s or Queen Charlotte’s
Hospital); gestation; birth weight; gender; clinical diagnoses; blood transfusions; survival to dis-
charge. Potential episodes of sepsis were identified from the diagnoses recorded in the elec-
tronic patient records and an additional database of all bacteremias arising from the neonatal
units during the study period which was provided by the microbiology laboratory. Local hourly
atmospheric CO measurements were obtained from the Department for the Environment and
Rural Affairs (http://uk-air.defra.gov.uk/). We defined the following terms prior to analysis:
onset of sepsis, as above; duration of sepsis, from onset of sepsis until antimicrobials were
stopped or death or discharge; suspected sepsis, any episode where there was antimicrobial
treatment but the Vermont Oxford Network definitions of early or late sepsis were not met; no
evidence of sepsis, absence of sepsis and suspected sepsis; recent blood transfusion, blood
transfusion on the same day or day prior to the sample collection. We used all data for analysis
without exclusion of outliers (although the accuracy of any apparent outlying results was veri-
fied against the original patient or laboratory records). Missing data was excluded with the
exception of environmental CO levels where we interpolated missing values for up to four one-
hour time periods by assuming a linear trend between the closest time points for which mea-
surements were available.
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Data were analysed in the R statistical programme using the packages lme4 and lmertest
[33]. In a pilot study we had found that trends in repeated measurements of COHb over time
were influenced by multiple factors including postnatal age, weight, oxyhemoglobin %, pH,
and subject identity. For this reason, our primary analysis was performed using a generalised
linear mixed-effects model, which allows for multiple covariates to be included and the effect
of sepsis to be determined in relation to the effect of these covariates. Subject identity was
included as a random factor, and the model was refined by step-wise removal of the least signif-
icant variables from a list of potentially relevant covariates until all variables in the model
remained significant (P<0.05). In order to determine the most important covariates this pro-
cess was first applied to data collected from all subjects at times when there was no suspected
or proven sepsis. The process was then repeated incorporating data collected at the onset of
sepsis in addition to the data collected when there was no evidence of sepsis. In simple terms,
this approach allows multiple measurements on each individual to be used, such that changes
in COHb can be assessed relative to the other measurements for that individual, but it also
allows the data on multiple individuals (both with and without sepsis, and at non-standardised
time points) to be combined in order to increase statistical power to detect effects of covariates.
Based on the numbers of neonates with sepsis seen each month in the neonatal units we
expected to be able to identify approximately 20 neonates fulfilling the sepsis definition from a
one-year period. Strictly speaking, this method of analysis does not require a control group
because longitudinal measurements of COHb allow each individual to act as their own control,
by comparing measurements during septic episodes with those in the absence of sepsis. There-
fore we arbitrarily included data only 5 additional subjects who had no episodes of sepsis.
Subject data are included as Supporting Information, S1 Table.
Results
Characteristics of study subjects
Fifty infants with a diagnosis of sepsis were screened for eligibility, of whom twenty-five ful-
filled the inclusion criteria for the sepsis group and did not have any exclusion criteria. Sixty-
three infants were screened for inclusion in the no sepsis group, of whom only five met the
strict inclusion criteria and had no exclusion criteria. Characteristics of the subjects are shown
in Table 1. Amongst the twenty-five neonates with sepsis twenty-two had one episode of sepsis,
and three had two episodes of sepsis. In all episodes of sepsis the pathogens were primarily iso-
lated from the blood, and no episodes were defined on the basis of a positive culture from
Table 1. Characteristics of study subjects.
Sepsis (n = 25) No sepsis (n = 5)
Gestational age, completed weeks + days. Median (range) 25+0 (23+2 to 34+5) 25+3 (25+2 to 27+0)
Birth weight, g.Median (range) 735 (460–1885) 740 (692–820)
Male, n (%) 14 (56%) 0 (0%)
Antenatal glucocorticoid, n (%) 23 (92%) 5 (100%)
Vaginal delivery, n (%) 17 (68%) 4 (80%)
Length of stay on neonatal unit, days. Median (range) 48.5 (1–392) 20 (3–78)
Number of carboxyhemoglobin measurements.Median (range) 34 (3–145) 17 (5–29)
At least one blood transfusion, n (%) 21 (84%) 4 (80%)
Respiratory distress syndrome, n (%) 24 (96%) 5 (100%)
Hypoxic ischemic encephalopathy, n (%) 0 (0%) 1 (20%)
Survived to discharge, n (%) 18 (72%) 2 (40%)
doi:10.1371/journal.pone.0161784.t001
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another sterile site without bacteremia. The distribution of causative organisms and the timing
of onset of infection is shown in Table 2.
Determinants of carboxyhemoglobin levels
In a pilot study we observed that COHb concentrations in neonates were strongly related to
postnatal age, so we began by examining this association in order to identify the best way to
handle age in our model. Restricting analysis to data collected when there was no evidence of
sepsis, we identified that COHb concentration declined with time from birth (Fig 1A). How-
ever closer inspection with postnatal age plotted on a logarithmic scale revealed that the
relationship was more complex (Fig 1B). There appeared to be an initial increase in COHb
reaching a peak about one day after birth, followed by a decrease until a steady state was
reached after about 8 weeks. This trend appeared to be well described by a third order polyno-
mial expression, and indeed this produced a much better explanation of the data than a linear
or quadratic solution, as demonstrated by the lower Akaike Information Criterion (AIC) and
Bayesian Information Criterion (BIC) (Table 3). Using this relationship to account for the
effect of age we constructed a linear mixed-effects model to identify covariates which might sig-
nificantly influence COHb concentration when there was no evidence of sepsis. This revealed
that COHb was positively associated with oxyhemoglobin saturation and hemoglobin concen-
tration, and negatively associated with gestational age and blood pH (Table 4). Of note, COHb
was not significantly associated with atmospheric CO, recent blood transfusion or neonatal
outcome (survival or death).
Relationship between onset of sepsis and carboxyhemoglobin levels
We repeated the process described above to evaluate if onset of sepsis was significantly associ-
ated with COHb levels in the linear mixed-effects model. Onset of sepsis was not associated
with any significant difference in COHb, and the best model (Table 5) remained very similar to
the model which only included measurements taken in the absence of sepsis. We repeated this
process to see whether any effect could be detected if the cause of sepsis was considered. Since
coagulase negative Staphylococci (CONS) often cause a more insidious illness (usually associ-
ated with infection of a central venous catheter) we explored whether onset of sepsis due to
CONS or non-CONS organisms may show differential association with COHb. This was not
the case. We also explored whether COHb may be differentially associated with early or late
onset sepsis, but again we found no significant associations. Overall this suggests that COHb is
not significantly different at the onset of sepsis when other covariates are taken into account.
We inspected the data from each individual subject to examine whether there was any obvious
relationship between COHb levels and episodes of sepsis (Fig 2). It was clear from this data
that in some cases elevated levels of COHb did occur during episodes of sepsis, but there was
Table 2. Characteristics of sepsis episodes.
Early Onset (n = 4) Late Onset (n = 24)
Group B Streptococcus 2 2
Escherichia coli 1 1
Coagulase-negative Staphylococci 0 17
Staphylococcus aureus 0 2
Other organisms 1 (Streptococcus gallolyticus) 2 (Acinetobacter species, Pseudomonas aeruginosa)
Survived, n (%) 3 (75%) 20 (83%)
Duration of sepsis in survivors, days. Median (range) 14 (5–14) 5 (5–14)
doi:10.1371/journal.pone.0161784.t002
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Fig 1. Variation in carboxyhemoglobin levels with postnatal age. (A) Carboxyhemoglobin levels plotted
against postnatal age on a linear scale. (B) Carboxyhemoglobin levels plotted against postnatal age on a
logarithmic scale. Solid line indicates the line of best fit using a third order polynomial (cubic) function and
shaded region indicates 95% confidence interval.
doi:10.1371/journal.pone.0161784.g001
Table 3. Comparison of models to explain the association of postnatal age with carboxyhemoglobin levels.
Model and variables† Akaike Information
Criterion
Bayesian Information
Criterion
Log
likelihood
Chi- squared P (for indicated
comparisons)
0. Intercept only (null) 1211 1225 -603 Reference
1. Age 1013 1031 -502 201 < 2.2 x10-16 vs. model 0
2. ln (Age) 891 909 -441 121 < 2.2 x10-16 vs. model 0
3. ln (Age) + (ln (Age))2 852 875 -421 41.1 1.48x10-10 vs. model 2
4. ln (Age) + (ln (Age))2 +
(ln (Age))3
814 841 -401 40.2 2.35x10-10 vs. model 3
†All models include subject identity as a random factor.
doi:10.1371/journal.pone.0161784.t003
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no consistent temporal pattern in relation to the start of the episode of sepsis. Overall, neonates
with and without sepsis seemed to have similar patterns of COHb with respect to age.
Discussion and Conclusion
The potential to identify hemolysis from detection of increased endogenous CO production
has been noted since at least 1949 [19, 34–36]. The realization that CO production also
Table 4. Linear mixed-effects model to describe the effect of variables on COHb levels in the absence of sepsis.
Variables included in model† Estimate (standard error) t value P
ln Age -4.97 x10-2 (2.91 x10-2) -1.71 0.087
(ln Age)2 -0.11 (1.47 x10-2) -7.13 2.68 x10-12
(ln Age)3 1.48 x10-2 (2.75 x10-3) 5.39 9.77 x10-8
Oxyhemoglobin (%) 6.54 x10-3 (1.67 x10-3) 3.92 9.83 x10-5
Gestational age (weeks) -8.45 x10-2 (1.66 x10-2) -5.09 3.55 x10-5
pH -0.53 (0.23) 2.32 0.020
Hemoglobin g/L 1.92 x10-3 (7.39 x10-4) 2.60 9.49 x10-3
Variables eliminated from model
Unit (St Mary’s / QCCH) NS
Atmospheric CO (ppm) NS
Gender NS
Methemoglobin (%) NS
Birthweight (g) NS
Recent blood transfusion NS
Outcome (survived/died) NS
†Based on 674 observations; all models include subject identity as a random factor. NS, not signiﬁcant (P>0.05) and therefore removed sequentially from
model.
doi:10.1371/journal.pone.0161784.t004
Table 5. Linear mixed-effects model to describe the effect of variables on COHb levels including data at the onset of sepsis.
Variables included in model† Estimate (standard error) t value P
ln Age -6.55 x10-2 (2.71 x10-2) -2.42 0.016
(ln Age)2 -6.53 x10-2 (9.34 x10-3) -6.99 6.41 x10-12
(ln Age)3 7.23 x10-3 (2.01 x10-3) 3.61 3.33 x10-4
Oxyhemoglobin (%) 5.57 x10-3 (1.73 x10-3) 3.22 1.33 x10-3
Gestational age (weeks) -7.38 x10-2 (1.68 x10-2) -4.40 2.18 x10-4
pH -0.52 (0.22) -2.34 0.019
Hemoglobin g/L 2.13 x10-3 (7.42 x10-4) 2.87 4.17 x10-3
Methemoglobin (%) 0.17 (5.35 x10-2) 2.18 0.030
Variables eliminated from model
Onset of sepsis NS
Unit (St Mary’s / QCCH) NS
Atmospheric CO (ppm) NS
Gender NS
Birthweight (g) NS
Recent blood transfusion NS
Outcome (survived/died) NS
†Based on 733 observations; all models include subject identity as a random factor. NS, not signiﬁcant (P>0.05) and therefore removed sequentially from
model.
doi:10.1371/journal.pone.0161784.t005
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increases in other circumstances when there is HO-1 induction, such as infection and systemic
inflammation [23–26], has also raised the possibility that CO may be a useful biomarker of
these conditions. Early diagnosis of infection in premature neonates can be challenging and
numerous biomarkers have been examined without any yet achieving the perfect combination
of being cheap and simple to measure whilst highly sensitive and specific [29, 37]. Since COHb
is so frequently measured during routine blood gas analysis in neonatal units, noting a sudden
change or sustained trend in COHb levels might aid the recognition of a new disease process.
In order to assess whether COHb could be clinically useful as a biomarker of sepsis or hemoly-
sis we need to understand which other factors influence COHb levels. Here we examined a
variety of factors which might influence COHb levels in a longitudinal dataset from preterm
neonates, and we tested whether COHb levels were significantly altered by the onset of sepsis.
Although we found that the onset of sepsis did not influence COHb concentrations, we did
characterise several other variables with an important influence on COHb levels. Most notable
of these was postnatal age, which will need to be accounted for in any studies investigating the
association between COHb and clinical diagnoses or outcomes.
Our study was conducted in a population predominantly composed of extremely preterm
and extremely low birth weight neonates, the most vulnerable population for risk of infection
[28]. We found that COHb levels increased over approximately the first 24 hours after birth,
before declining over the next 8 weeks to a steady value. The initial increase in COHb could
reflect the change from feto-placental to postnatal circulation, because the CO binding affinity
of fetal hemoglobin is lower than that of hemoglobin A [38]. Thus in utero COmight preferen-
tially cross the placenta to the maternal blood, resulting in levels of COHb in the neonate
immediately after birth which are lower than expected for the amount of endogenous CO pro-
duction. Other possible explanations include an increase in HO-1 expression in response to
Fig 2. Carboxyhemoglobin levels in individual subjects in relation to postnatal age and episodes of sepsis. Trellis plot of COHb levels over
time (ln (Age)) for each individual subject and relationship to presence or absence of sepsis (red, no sepsis; blue, suspected sepsis; orange, onset
of proven sepsis; green, established sepsis). Timing and cause of sepsis are indicated for each individual (EO, early onset; LO, late onset; GBS,
Group B Streptococcus; CONS, coagulase-negative Staphylococcus; Pseud, Pseudomonas aeruginosa; Acinetobacter, Acinetobacter sp.)
doi:10.1371/journal.pone.0161784.g002
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birth [39], and/or an increase in the rate of heme catabolism from fetal red blood cells after
birth. Following the initial rise, COHb levels declined over a time course reminiscent of the nat-
ural fall in hemoglobin concentration after birth [40]. The shortened lifespan of fetal red blood
cells, particularly those from preterm infants [40], might perhaps explain this through an
increased rate of heme catabolism until these cells are eventually all removed from the circula-
tion. Finally a steady state level of COHb was reached at around 8 weeks, which is close to the
expected nadir for hemoglobin concentration [40]. COHb was positively associated with oxy-
hemoglobin saturation, as we previously observed in a cross-sectional study of children in
Kenya [22], and this likely represents the fact that at low concentrations of both CO and oxy-
gen there is enhancement of binding to hemoglobin [41, 42]. We also found that COHb levels
were inversely correlated with gestational age (as previously noted by others [43]), and posi-
tively associated with hemoglobin concentration, two observations which may both be related
to the generation of CO from more rapid destruction of fetal red cells after birth. Prematurity
is associated with a lower hemoglobin concentration and red cell mass at the time of birth [44],
and the fetal red cell mass dictates the amount of heme which will be catabolised during the
shorter lifespan of fetal erythrocytes [40]. The negative association of COHb with pH was
unexpected, since low pH has been reported to enhance CO dissociation from hemoglobin
[45], however acidosis can also induce HO-1 expression [46]. The positive association with
methemoglobin (at least in the analysis including onset of sepsis) is not surprising since methe-
moglobin formation precedes the liberation of heme from hemoglobin, and hence increased
methemoglobin is likely to indicate increased heme availability and therefore CO production
[47, 48]. We did not find any association of COHb with onset of sepsis, suggesting that COHb
would not be a useful biomarker of sepsis in this population.
Our study has a number of limitations, primarily due to its retrospective nature and the con-
straints this imposes on data availability and data quality. We did not have any control over
the timing of samples or the reason for blood sampling, which means that samples were most
likely to be collected when infants were most unwell. We did not have reliable data to indicate
whether samples were arterial, venous or capillary in origin, which may be important because
differences in arterial and venous COHb have been reported to occur and to be greater in the
presence of lung disease [49, 50]. However we believe this would not have a major confounding
effect because common practice in our neonatal unit is to collect capillary samples, with a
smaller proportion of venous origin, and very few of arterial origin. We were unable to extract
accurate information about artificial ventilation parameters and supplemental oxygen concen-
trations from the electronic patient records and so were unable to adjust for these in our analy-
sis. Another limitation is the use of COHb levels measured on a blood co-oximeter, and the
assumption that this reflects endogenous CO production. More accurate methods exist for
determination of CO content in blood [51], and for measurement of endogenous CO produc-
tion [52], but none of these are practical to apply to a longitudinal study with repeated samples
collected from extremely small and often very ill neonates. Our approach was deliberately prag-
matic, since we sought to identify whether the COHb levels which are routinely measured as
part of blood gas analysis were of any utility for the identification of sepsis.
Our study is not the first to examine COHb levels in neonates, but we believe that it provides
the most complete characterization of COHb levels over time after birth, and it is the first to
examine whether the onset of sepsis is independently associated with COHb levels. In contrast
to another study we found no association of COHb levels with survival [43], but this may sim-
ply reflect the smaller number of infants in our study. The lack of an increase in COHb at the
onset of sepsis in our study may reflect the nature of the inflammatory response to sepsis in
extremely premature infants which also results in reduced sensitivity of conventional markers
of sepsis [28, 29]. We excluded infants with necrotising enterocolitis from our study in order to
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prevent it confounding relationships between COHb and sepsis, but the relationships between
COHb and necrotizing enterocolitis may be interesting to study in their own right. It is known
that HO-1 expression is increased in the intestines of infants with necrotising enterocolitis,
whilst carbon monoxide protects from necrotising enterocolitis-like pathology in neonatal rats
[32]. Therefore future studies may be justified to examine whether COHb levels in extremely
preterm infants have value in predicting risk or making an early diagnosis of necrotising
enterocolitis.
Our findings have several implications. First the raw data themselves (Fig 2) highlight the
considerable variability of COHb levels between and within individuals. We have characterised
some variables which account for some of this variation, most notably postnatal age. These var-
iations suggest that tests for hemolysis or other pathological processes based on measurement
of exhaled CO or COHb may not perform as well in a real world setting as they might in care-
fully controlled trials. Accounting for the variations due to postnatal age, pH, hemoglobin, oxy-
hemoglobin, and gestational age will introduce a level of complexity which is difficult to adapt
to clinical practice. However knowledge of these potential confounding variables may be useful
in future studies seeking to identify biological relationships between COHb and pathological
processes, for example necrotising entercolitis as mentioned above. Whilst we found no associ-
ation between onset of sepsis and COHb, inspection of the data in Fig 2 does suggest that some
of the highest levels of COHb tended to occur during episodes of sepsis. It would therefore be
prudent for clinicians to be aware of possible reasons for elevated COHb in a neonate, and to
consider carefully whether there may be an underlying reason.
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